Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neurons

BACKGROUND: Triptans, 5-HT(1B/ID )agonists, act on peripheral and/or central terminals of trigeminal ganglion neurons (TGNs) and inhibit the release of neurotransmitters to second-order neurons, which is considered as one of key mechanisms for pain relief by triptans as antimigraine drugs. Although high-voltage activated (HVA) Ca(2+ )channels contribute to the release of neurotransmitters from TGNs, electrical actions of triptans on the HVA Ca(2+ )channels are not yet documented. RESULTS: In the present study, actions of zolmitriptan, one of triptans, were examined on the HVA Ca(2+ )channels in acutely dissociated rat TGNs, by using whole-cell patch recording of Ba(2+ )currents (I(Ba)) passing through Ca(2+ )channels. Zolmitriptan (0.1–100 μM) reduced the size of I(Ba )in a concentration-dependent manner. This zolmitriptan-induced inhibitory action was blocked by GR127935, a 5-HT(1B/1D )antagonist, and by overnight pretreatment with pertussis toxin (PTX). P/Q-type Ca(2+ )channel blockers inhibited the inhibitory action of zolmitriptan on I(Ba), compared to N- and L-type blockers, and R-type blocker did, compared to L-type blocker, respectively (p < 0.05). All of the present results indicated that zolmitriptan inhibited HVA P/Q- and possibly R-type channels by activating the 5-HT(1B/1D )receptor linked to G(i/o )pathway. CONCLUSION: It is concluded that this zolmitriptan inhibition of HVA Ca(2+ )channels may explain the reduction in the release of neurotransmitters including CGRP, possibly leading to antimigraine effects of zolmitriptan.